Universal Influenza Vaccine Technology Landscape

The Landscape is a database of novel vaccine candidates designed to provide broader and more durable protection against circulating and pandemic influenza viruses, compared with current strain-specific seasonal influenza vaccines. CIDRAP is developing the landscape with support from the Global Funders Consortium for Universal Influenza Vaccine Development.

Tracker

Vaccine Candidates 175 Vaccine Candidates
Vaccine in clinical trials 35 Vaccines in Clinical Trials
COVID+Flu Vaccine Candidates 4 COVID+Flu Vaccine Candidates
Developers 138 Developers
Platforms 6 Platforms
Preclinical 140
Phase 1 21
Phase 2 9
Phase 3 5
Approved 0

Database

Previous Next
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Platform

Recombinant proteins

36
Vaccines in
Preclinical
1
Vaccines in
Phase 1
1
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Recombinant influenza virus-based

12
Vaccines in
Preclinical
3
Vaccines in
Phase 1
2
Vaccines in
Phase 2
0
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Virus-vectored

20
Vaccines in
Preclinical
2
Vaccines in
Phase 1
3
Vaccines in
Phase 2
0
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Virus-like particles (VLP)

24
Vaccines in
Preclinical
2
Vaccines in
Phase 1
0
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Non-VLP nanoparticles

28
Vaccines in
Preclinical
4
Vaccines in
Phase 1
2
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved